NEW Short version available
The ICS is pleased to announce that a new short version of the Best Practice Statement for the Use of Sacral Neuromodulation is now available:
Click Here to download
Published in Neurourology and Urodynamics Journal, this is an abridged version of the full document. Should you wish to download the full document please see below.
ICS Best Practice Statement for the Use of Sacral Neuromodulation Published
While sacral neuromodulation (SNM) is an accepted therapy for multiple urinary and bowel indications there is no comprehensive document that physicians and other caregivers can turn to that reflects best practices across indications. Furthermore, there is a paucity of published literature related to many of the practical aspects of sacral neuromodulation. Thus, under the aegis of the ICS, a geographically-diverse panel of expert urologists, urogynecologists and colorectal surgeons was convened for two days in January 2017 and tasked with formulating practical recommendations concerning SNM to be used by other clinicians.
Utilising available data and expert opinion, best practice statements were formulated and supporting discussion was prepared. Some of the topics covered include urinary and bowel indications for SNM (both approved and “non-approved”), need for testing prior to SNM, contraindications to SNM, appropriate patient counselling, rationale for PNE versus staged testing, appropriate measures of improvement, infection prevention and management, appropriate anaesthesia, tips for implant success, the role of fluoroscopy, IPG placement, post-procedural patient restrictions, post-operative care and follow-up, dealing with device malfunction or a non-functioning system, residual lead fragments, the role of bilateral and pudendal leads, MRI concerns and future research.
The document was then reviewed by multiple external reviewers representing the different specialities and again covering a global swath. This was done to take into consideration potential practice pattern variations that might be evident in different locales. Based on reviewer comments, edits were made, other references were included and the manuscript was ultimately finalised.
The final document is being published in Neurourology and Urodynamics (the official journal of the ICS) and will be available on the ICS website. This document should allow practitioners to readily identify best practices supported by the literature and/or expert opinion and assist in appropriate patient selection, counselling, surgery and overall management of patients who undergo SNM
This effort was supported by an unrestricted grant from Medtronic to the ICS.
International Continence Society best practice statement for use of sacral neuromodulation, short, DOI: 10.1002/nau.23596
International Continence Society best practice statement for use of sacral neuromodulation, DOI: 10.1002/nau.23515
International Continence Society best practice statement for use of sacral neuromodulation, PDF